Ghezzi Fabio, Cromi Antonella, Uccella Stefano, Siesto Gabriele, Zefiro Francesca, Bolis Pierfrancesco
Department of Obstetrics and Gynecology, University of Insubria, Del Ponte Hospital, Varese, Italy.
Ann Surg Oncol. 2009 Aug;16(8):2305-14. doi: 10.1245/s10434-009-0514-5. Epub 2009 May 21.
Feasibility and safety of laparoscopic management of gynecologic cancers have been established by numerous clinical trials. However, the degree to which such results are achievable outside the context of formal research programs and the actual extent of laparoscopy uptake since its introduction are unclear. Purpose of this study was to examine the impact upon operative and cancer outcomes of the incorporation of laparoscopy into the surgical practice of our gynecologic oncology service.
Data from 383 consecutive women undergoing surgery for the treatment of an apparently early-stage gynecologic cancer between 2000 and 2008 were analyzed. Integration of minimally access surgery for the treatment of invasive malignancies began with borderline ovarian tumors in 2001 and proceeded sequentially to include endometrial, ovarian, and cervical cancer patients.
The annual proportion of laparoscopic cases has increased significantly over the study period from 7.7% in 2001 to 90.9% in 2008 (P < 0.0001 for trend). A temporal trend toward reduction in estimated blood loss was observed in both endometrial cancer and cervical cancer patients (P < 0.0001). There was a significant decrease in the percentage of patients requiring blood transfusions [18 (17.1%) during the period 2000-2002, 19 (13.6%) during 2003-2005, and 8 (5.8%) during 2006-2008; P = 0.005 for trend]. Length of hospital stay has decreased significantly over time for all disease sites (P < 0.0001 for endometrial and cervical cancer; P = 0.02 for ovarian cancer). No difference was found in median operative time, number of lymph nodes harvested, complication rates, 1- and 2-year disease-free survival, and overall survival when data of subsequent time periods were compared.
Substantial utilization of laparoscopy in the existing practice of a gynecologic oncology service provided benefits to patients without detrimental effects on clinical outcomes. The relatively short follow-up time of laparoscopic cases disallows firm conclusions on long-term survival.
众多临床试验已证实腹腔镜治疗妇科癌症的可行性和安全性。然而,在正规研究项目之外能在多大程度上取得这样的结果,以及自腹腔镜技术引入以来其实际应用范围尚不清楚。本研究的目的是探讨将腹腔镜技术纳入我们妇科肿瘤服务的手术实践对手术及癌症治疗结果的影响。
分析了2000年至2008年间连续383例接受手术治疗的疑似早期妇科癌症患者的数据。2001年开始将微创外科手术用于治疗侵袭性恶性肿瘤,最初是交界性卵巢肿瘤,随后依次纳入子宫内膜癌、卵巢癌和宫颈癌患者。
在研究期间,腹腔镜手术病例的年度比例显著增加,从2001年的7.7%增至2008年的90.9%(趋势P<0.0001)。子宫内膜癌和宫颈癌患者均观察到估计失血量呈时间趋势减少(P<0.0001)。需要输血的患者百分比显著下降[2000 - 2002年期间为18例(17.1%),2003 - 2005年期间为19例(13.6%),2006 - 2008年期间为8例(5.8%);趋势P = 0.005]。所有疾病部位的住院时间均随时间显著缩短(子宫内膜癌和宫颈癌P<0.0001;卵巢癌P = 0.02)。比较后续时间段的数据时,中位手术时间、切除淋巴结数量、并发症发生率、1年和2年无病生存率以及总生存率均未发现差异。
在妇科肿瘤服务的现有实践中大量使用腹腔镜技术对患者有益,且对临床结果无不利影响。腹腔镜手术病例相对较短的随访时间不允许对长期生存得出确凿结论。